Becton Dickinson & Co (NYSE:BDX)
$ 221.9 -0.08 (-0.04%) Market Cap: 64.16 Bil Enterprise Value: 82.13 Bil PE Ratio: 37.36 PB Ratio: 2.48 GF Score: 85/100

Becton Dickinson and Co at Jefferies London Healthcare Conference Transcript

Nov 21, 2019 / 11:20AM GMT
Release Date Price: $242.72 (+0.88%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. We'll go ahead and get started. Thanks everybody for joining us. I'm Brandon Couillard, I cover Lifescience Tools and Diagnostics sector here in Equity Research at Jefferies. Very happy to have Becton, Dickinson with us at the conference this year. As you can tell, format today will be a fireside chat. Anyone in the audience who has a question, feel free to raise your hand. Happy to have participation in the audience.

Joining us from the company, Mr. John Gallagher, here first to my left, who's the SVP and CFO of the Medical Division; and then Simon Campion, who heads up the BD Interventional segment.

Questions & Answers

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

And maybe just to start off, John and Simon, at a very high level, Vincent now, he's stepping down later this year. Tom Polen kind of taking over the CEO post at the end of the year. Just kind of touch on any differences in operational style between those 2, any changes in sort

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot